Al-Louzi Lab

The Al-Louzi Laboratory conducts research to identify the causes of visual loss and clinical disability in multiple sclerosis (MS), neuroimmunology and neurological disorders. To achieve this goal, the Al-Louzi Laboratory is focused on human clinical and translational research using functional and retinal structural imaging, in combination with cutting-edge technological advances in magnetic resonance imaging (MRI), to examine pathological changes in the visual pathway and study their association with relevant clinical disease outcome metrics and pathobiological processes.

The overarching goal of the Al-Louzi Laboratory is to find ways to mitigate or prevent visual and clinical disability from neurological illness before it occurs. The Al-Louzi Laboratory is affiliated with the Cedars-Sinai Department of Neurology & Neurosurgery and the Neuroimaging Program.